Xiaoran Ding

577 total citations
21 papers, 494 citations indexed

About

Xiaoran Ding is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Xiaoran Ding has authored 21 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Xiaoran Ding's work include Hepatitis B Virus Studies (8 papers), RNA Interference and Gene Delivery (6 papers) and Molecular Biology Techniques and Applications (3 papers). Xiaoran Ding is often cited by papers focused on Hepatitis B Virus Studies (8 papers), RNA Interference and Gene Delivery (6 papers) and Molecular Biology Techniques and Applications (3 papers). Xiaoran Ding collaborates with scholars based in China and United States. Xiaoran Ding's co-authors include Shengqi Wang, Jing Yang, Xuejun Wang, Zhe Zhou, Xiaochen Bo, Jing Yang, Ying Li, Xiujuan Zhang, Wei Hu and Junzhi Wang and has published in prestigious journals such as PLoS ONE, Chemical Engineering Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaoran Ding

20 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoran Ding China 12 254 181 154 115 76 21 494
Xue Hu China 16 318 1.3× 225 1.2× 58 0.4× 99 0.9× 155 2.0× 47 624
Wensong Jin China 9 367 1.4× 196 1.1× 270 1.8× 40 0.3× 97 1.3× 13 540
Gaofeng Lu China 13 192 0.8× 106 0.6× 71 0.5× 62 0.5× 77 1.0× 17 461
Stephanie T. Chan United States 6 189 0.7× 229 1.3× 88 0.6× 77 0.7× 78 1.0× 7 414
Jesse Donovan United States 15 742 2.9× 117 0.6× 133 0.9× 364 3.2× 123 1.6× 16 1.1k
Mengdie Fang China 10 215 0.8× 201 1.1× 84 0.5× 53 0.5× 32 0.4× 21 437
Ching‐Shu Suen Taiwan 13 278 1.1× 88 0.5× 43 0.3× 63 0.5× 44 0.6× 22 492
Xiaoang Yang China 9 206 0.8× 70 0.4× 69 0.4× 198 1.7× 24 0.3× 15 396
Shipin Wu China 11 143 0.6× 67 0.4× 70 0.5× 64 0.6× 43 0.6× 18 288
Zvi Shalev Israel 12 230 0.9× 90 0.5× 69 0.4× 127 1.1× 17 0.2× 16 491

Countries citing papers authored by Xiaoran Ding

Since Specialization
Citations

This map shows the geographic impact of Xiaoran Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoran Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoran Ding more than expected).

Fields of papers citing papers by Xiaoran Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoran Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoran Ding. The network helps show where Xiaoran Ding may publish in the future.

Co-authorship network of co-authors of Xiaoran Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoran Ding. A scholar is included among the top collaborators of Xiaoran Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoran Ding. Xiaoran Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qingzhen, Liyan Liu, Qiqi Liu, et al.. (2024). Genetic identification of human remains from the Korean War. Electrophoresis. 45(15-16). 1356–1369.
2.
Zhang, Zherui, Jiamei Gu, Xiaoran Ding, et al.. (2022). Bioresponsive cisplatin crosslinked albumin hydrogel served for efficient cancer combination therapy. Nano Research. 16(2). 2762–2774. 9 indexed citations
3.
Wang, Zhongyuan, Xiaoran Ding, Yan Li, & Jiangbo Xie. (2022). The compensation effect between safety and efficiency in xylem and role in photosynthesis of gymnosperms. Physiologia Plantarum. 174(1). e13617–e13617. 6 indexed citations
4.
Zhang, Qingzhen, Zhe Zhou, Qiqi Liu, et al.. (2018). Evaluation of the performance of Illumina's ForenSeq™ system on serially degraded samples. Electrophoresis. 39(21). 2674–2684. 15 indexed citations
5.
Zhang, Li, Qingjun Li, Xiaoran Ding, et al.. (2017). Antisense Oligonucleotides Targeting Raf-1 Block Japanese Encephalitis Virus In Vitro and In Vivo. Nucleic Acid Therapeutics. 27(2). 78–86. 8 indexed citations
6.
Liu, Qiqi, Liyan Liu, Minli Zhang, et al.. (2017). A Simple and Efficient Method of Extracting DNA from Aged Bones and Teeth. Journal of Forensic Sciences. 63(3). 824–828. 11 indexed citations
7.
Qu, Xinyan, Xiaoran Ding, Ming Duan, et al.. (2016). Influenza virus infection induces translocation of apoptosis-inducing factor (AIF) in A549 cells: role of AIF in apoptosis and viral propagation. Archives of Virology. 162(3). 669–675. 12 indexed citations
8.
Fu, Xinyu, et al.. (2016). The synergistic antiviral effects of GSH in combination with acyclovir against BoHV-1 infection in vitro. Acta Virologica. 60(3). 328–332. 9 indexed citations
9.
Yang, Jing, Li Kang, Xiaoran Ding, et al.. (2013). Proteomic analysis at the subcellular level for host targets against influenza A virus (H1N1). Antiviral Research. 100(3). 673–687. 11 indexed citations
10.
Yang, Jing, Xingliang Fan, Wei Hu, et al.. (2012). Cellular microRNA let‐7c inhibits M1 protein expression of the H1N1 influenza A virus in infected human lung epithelial cells. Journal of Cellular and Molecular Medicine. 16(10). 2539–2546. 101 indexed citations
11.
Hu, Wei, Xuejun Wang, Xiaoran Ding, et al.. (2012). MicroRNA-141 Represses HBV Replication by Targeting PPARA. PLoS ONE. 7(3). e34165–e34165. 93 indexed citations
12.
Yang, Jing, Juan Liu, Xiaoran Ding, et al.. (2012). Inhibition of Hepatitis B virus replication by Phospholipid scramblase 1 in vitro and in vivo. Antiviral Research. 94(1). 9–17. 24 indexed citations
13.
Hu, Wei, Xuejun Wang, Xiaoran Ding, et al.. (2012). Correction: MicroRNA-141 Represses HBV Replication by Targeting PPARA. PLoS ONE. 7(7). 8 indexed citations
14.
Ding, Xiaoran, Jing Yang, & Shengqi Wang. (2011). Antisense Oligonucleotides Targeting Abhydrolase Domain Containing 2 Block Human Hepatitis B Virus Propagation. Oligonucleotides. 21(2). 77–84. 16 indexed citations
15.
Yang, Jing, Feng Wang, Jing Su, et al.. (2010). Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface. Archives of Virology. 155(6). 881–888. 19 indexed citations
16.
Ding, Xiaoran, et al.. (2008). Epiregulin as a key molecule to suppress hepatitis B virus propagation in vitro. Archives of Virology. 154(1). 9–17. 7 indexed citations
17.
Ding, Xiaoran, et al.. (2007). Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs. The Pharmacogenomics Journal. 8(1). 61–70. 23 indexed citations
18.
Zhou, Zhe, Yi Zhang, Xiaoran Ding, et al.. (2007). Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo. Antiviral Research. 74(1). 59–64. 83 indexed citations
19.
Yang, Jing, Xiaoran Ding, Yi Zhang, et al.. (2006). Fibronectin is essential for hepatitis B virus propagation in vitro: May be a potential cellular target?. Biochemical and Biophysical Research Communications. 344(3). 757–764. 12 indexed citations
20.
Yang, Jing, et al.. (2005). Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication. Journal of Viral Hepatitis. 13(3). 158–165. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xue Hu Breakdown of academic impact, for papers by Wensong Jin Breakdown of academic impact, for papers by Gaofeng Lu Breakdown of academic impact, for papers by Stephanie T. Chan Breakdown of academic impact, for papers by Jesse Donovan Breakdown of academic impact, for papers by Mengdie Fang Breakdown of academic impact, for papers by Ching‐Shu Suen Breakdown of academic impact, for papers by Xiaoang Yang Breakdown of academic impact, for papers by Shipin Wu Breakdown of academic impact, for papers by Zvi Shalev
Rankless by CCL
2026